Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment

Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment